651 - 700 of 9038 Results
Title
Year
- The genetics of Parkinson disease2018RESTRICTEDTitle: The genetics of Parkinson diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 42Issue #:Start Page: 72End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2017.12.007Citation Count: 386
- Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillations2016RESTRICTEDTitle: Sixty‐hertz stimulation improves bradykinesia and amplifies subthalamic low‐frequency oscillationsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 1Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26837Citation Count: 63
- Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease2019RESTRICTEDTitle: Targeting of the unfolded protein response (UPR) as therapy for Parkinson's diseaseJournal Name: Biology of the CellPublisher: WileyVol: 111Issue #: 6Start Page: 161End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/boc.201800068Citation Count: 36
-
RESTRICTEDTitle: Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and PathologyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 20Issue #: 1Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms20010141Best OA location URL: https://www.mdpi.com/1422-0067/20/1/141/pdf?version=1546425034Citation Count: 55
-
RESTRICTEDTitle: Resting-state fMRI in Parkinson's disease patients with cognitive impairment: A meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 16End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.016Best OA location URL: https://cris.maastrichtuniversity.nl/files/76214281/Leentjens_2019_Resting_state_fMRI_in_Parkinsons.pdfCitation Count: 129
-
RESTRICTEDTitle: Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?Journal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 7Start Page: 957End Page: 957Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12070957Best OA location URL: https://www.mdpi.com/2218-273X/12/7/957/pdf?version=1657271910Citation Count: 14
- Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?2021RESTRICTEDTitle: Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?Journal Name: BiomoleculesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 40End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom12010040Best OA location URL: https://www.mdpi.com/2218-273X/12/1/40/pdf?version=1640831739Citation Count: 4
-
RESTRICTEDTitle: Prodromal Cognitive Deficits and the Risk of Subsequent Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 2Start Page: 199End Page: 199Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12020199Best OA location URL: https://www.mdpi.com/2076-3425/12/2/199/pdf?version=1643638610Citation Count: 5
-
RESTRICTEDTitle: A New Rise of Non-Human Primate Models of SynucleinopathiesJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 3Start Page: 272End Page: 272Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9030272Best OA location URL: https://www.mdpi.com/2227-9059/9/3/272/pdf?version=1615293914Citation Count: 9
-
RESTRICTEDTitle: LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 11Issue #: 8Start Page: 1101End Page: 1101Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom11081101Best OA location URL: https://www.mdpi.com/2218-273X/11/8/1101/pdf?version=1627473313Citation Count: 26
-
RESTRICTEDTitle: Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient CellsJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 5Start Page: 981End Page: 981Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10050981Best OA location URL: https://www.mdpi.com/2073-4409/10/5/981/pdf?version=1619174268Citation Count: 6
-
RESTRICTEDTitle: Animal Models of Autosomal Recessive ParkinsonismJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 7Start Page: 812End Page: 812Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9070812Best OA location URL: https://www.mdpi.com/2227-9059/9/7/812/pdf?version=1626351984Citation Count: 7
-
RESTRICTEDTitle: Alpha-Synuclein and Lipids: The Elephant in the Room?Journal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2452End Page: 2452Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092452Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2452/pdf?version=1632375393Citation Count: 22
-
RESTRICTEDTitle: Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic OpportunitiesJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 18Start Page: 2908End Page: 2908Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11182908Best OA location URL: https://www.mdpi.com/2073-4409/11/18/2908/pdf?version=1663735802Citation Count: 34
-
RESTRICTEDTitle: Calcium, Bioenergetics, and Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 9Start Page: 2045End Page: 2045Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9092045Best OA location URL: https://www.mdpi.com/2073-4409/9/9/2045/pdfCitation Count: 51
-
RESTRICTEDTitle: Multiple Chemical SensitivityJournal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 46End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12010046Best OA location URL: https://www.mdpi.com/2076-3425/12/1/46/pdf?version=1641182918Citation Count: 19
-
RESTRICTEDTitle: Senescence as an Amyloid Cascade: The Amyloid Senescence HypothesisJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2020.00129Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2020.00129/pdfCitation Count: 34
-
RESTRICTEDTitle: Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological DisordersJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2014.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2014.00271/pdfCitation Count: 41
-
RESTRICTEDTitle: A Role for the Brain RAS in Alzheimer’s and Parkinson’s DiseasesJournal Name: Frontiers in EndocrinologyPublisher: Frontiers Media SAVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fendo.2013.00158Best OA location URL: https://www.frontiersin.org/articles/10.3389/fendo.2013.00158/pdfCitation Count: 82
-
RESTRICTEDTitle: CNS active O-linked glycopeptidesJournal Name: Frontiers in ChemistryPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fchem.2015.00040Best OA location URL: https://www.frontiersin.org/articles/10.3389/fchem.2015.00040/pdfCitation Count: 30
-
RESTRICTEDTitle: Linear Ubiquitin Chains: Cellular Functions and Strategies for Detection and QuantificationJournal Name: Frontiers in ChemistryPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fchem.2019.00915Best OA location URL: https://www.frontiersin.org/articles/10.3389/fchem.2019.00915/pdfCitation Count: 71
-
RESTRICTEDTitle: Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the RescueJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.673205Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.673205/pdfCitation Count: 23
-
RESTRICTEDTitle: LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal ModelsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00719Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00719/pdfCitation Count: 13
-
RESTRICTEDTitle: LRRK2-Related Parkinson’s Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A HypothesisJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00556Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00556/pdfCitation Count: 20
-
RESTRICTEDTitle: Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s DiseaseJournal Name: Frontiers in PharmacologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphar.2019.01294Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphar.2019.01294/pdfCitation Count: 32
-
RESTRICTEDTitle: The Role of Ubiquitin in Regulating Stress Granule DynamicsJournal Name: Frontiers in PhysiologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphys.2022.910759Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphys.2022.910759/pdfCitation Count: 12
-
RESTRICTEDTitle: Deubiquitinating Enzymes in Parkinson’s DiseaseJournal Name: Frontiers in PhysiologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphys.2020.00535Best OA location URL: https://www.frontiersin.org/articles/10.3389/fphys.2020.00535/pdfCitation Count: 14
-
RESTRICTEDTitle: The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial BioenergeticsJournal Name: Frontiers in OncologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fonc.2017.00055Best OA location URL: https://www.frontiersin.org/articles/10.3389/fonc.2017.00055/pdfCitation Count: 39
-
RESTRICTEDTitle: Striatal cholinergic interneuron regulation and circuit effectsJournal Name: Frontiers in Synaptic NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsyn.2014.00022Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnsyn.2014.00022/pdfCitation Count: 176
- c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease2016RESTRICTEDTitle: c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00254Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00254/pdfCitation Count: 38
-
RESTRICTEDTitle: Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's DiseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00500Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00500/pdfCitation Count: 127
-
RESTRICTEDTitle: Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic ReviewJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.531993Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.531993/pdfCitation Count: 49
- Sudden Death and Cardiac Arrythmia With Lamotrigine2022RESTRICTEDTitle: Sudden Death and Cardiac Arrythmia With LamotrigineJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000200164Citation Count: 17
-
RESTRICTEDTitle: Genome-wide Association and Meta-analysis of Age at Onset in Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200699Best OA location URL: https://n.neurology.org/content/neurology/99/7/e698.full.pdfCitation Count: 26
-
RESTRICTEDTitle: Neuroprotective Trials in REM Sleep Behavior DisorderJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 19End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200235Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/19.full.pdfCitation Count: 21
-
RESTRICTEDTitle: Who to Enroll in Parkinson Disease Prevention Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 10End Page: 18Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200812Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/10.full.pdfCitation Count: 8
-
RESTRICTEDTitle: Path to Parkinson Disease PreventionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 76End Page: 83Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200793Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/76.full.pdfCitation Count: 14
-
RESTRICTEDTitle: The UPRosome – decoding novel biological outputs of IRE1α functionJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol: 133Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1242/jcs.218107Best OA location URL: https://journals.biologists.com/jcs/article-pdf/133/15/jcs218107/1987768/jcs218107.pdfCitation Count: 38
-
RESTRICTEDTitle: Meta-analysis of whole-exome sequencing data from two independent cohorts finds no evidence for rare variant enrichment in Parkinson disease associated lociJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 10Start Page: e0239824End Page: e0239824Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0239824Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0239824&type=printableCitation Count: 11
-
RESTRICTEDTitle: Recent advances in understanding and treatment of Parkinson’s diseaseJournal Name: Faculty ReviewsPublisher: Faculty Opinions LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.12703/b/9-6Best OA location URL: https://facultyopinions.com/prime/reports/b/9/6/pdfCitation Count: 10
-
RESTRICTEDTitle: Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for FallsJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 11Issue #: 3Start Page: 679End Page: 679Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2019.0805Best OA location URL: https://doi.org/10.14336/ad.2019.0805Citation Count: 36
- The role of neurotransmitters in the development of Parkinson's disease‐related psychosis2017RESTRICTEDTitle: The role of neurotransmitters in the development of Parkinson's disease‐related psychosisJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 10Start Page: 1244End Page: 1254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.13376Citation Count: 48
-
RESTRICTEDTitle: Can Parkinson's disease pathology be propagated from one neuron to another?Journal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 97Issue #: 2Start Page: 205End Page: 219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2011.11.003Best OA location URL: https://lup.lub.lu.se/search/files/1962759/2363521.pdfCitation Count: 98
-
RESTRICTEDTitle: Sleep disorders and Parkinson disease; lessons from geneticsJournal Name: Sleep Medicine ReviewsPublisher: Elsevier BVVol: 41Issue #:Start Page: 101End Page: 112Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smrv.2018.01.006Best OA location URL: http://escholarship.mcgill.ca/downloads/tb09j975fCitation Count: 33
-
RESTRICTEDTitle: Palmaris Brevis Syndrome: A Treatable PseudodystoniaJournal Name: Tremor and Other Hyperkinetic MovementsPublisher: Ubiquity Press, Ltd.Vol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.5334/tohm.659Best OA location URL: http://tremorjournal.org/articles/10.5334/tohm.659/galley/1580/download/Citation Count: 1
- Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic review2020RESTRICTEDTitle: Medical cannabis as an alternative therapeutics for Parkinsons’ disease: Systematic reviewJournal Name: Complementary Therapies in Clinical PracticePublisher: Elsevier BVVol: 39Issue #:Start Page: 101154End Page: 101154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ctcp.2020.101154Citation Count: 17
- Emerging therapeutic developments in neurodegenerative diseases: A clinical investigation2022RESTRICTEDTitle: Emerging therapeutic developments in neurodegenerative diseases: A clinical investigationJournal Name: Drug Discovery TodayPublisher: Elsevier BVVol: 27Issue #: 10Start Page: 103305End Page: 103305Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.drudis.2022.06.005Citation Count: 11
- RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson’s Disease2020RESTRICTEDTitle: RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson’s DiseaseJournal Name: Molecular PharmacologyPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 98Issue #: 6Start Page: 730End Page: 738Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/mol.119.118836Best OA location URL: https://molpharm.aspetjournals.org/content/molpharm/98/6/730.full.pdfCitation Count: 12
-
RESTRICTEDTitle: Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 74Issue #: 1Start Page: 207End Page: 237Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1124/pharmrev.120.000133Best OA location URL: https://pharmrev.aspetjournals.org/content/pharmrev/74/1/207.full.pdfCitation Count: 39
-
RESTRICTEDTitle: Parkinson Disease: Translating Insights from Molecular Mechanisms to NeuroprotectionJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 73Issue #: 4Start Page: 1204End Page: 1268Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pharmrev.120.000189Best OA location URL: https://pharmrev.aspetjournals.org/content/pharmrev/73/4/1204.full.pdfCitation Count: 10